Skip to main content

Table 3 Univariate analysis of GSTM3 expression and clinicopathological factors for DSS and DFS in mRNA cohort patients with ESCC

From: Low GSTM3 expression is associated with poor disease‐free survival in resected esophageal squamous cell carcinoma

Characteristic Cases Disease-specific survival (DSS) (%) P# Disease-free survival (DFS) (%) P#
3-year DSS 5-year DSS 3-year DFS 5-year DFS
Gender     0.450    0.830
 Male 135 60.6 50.8   49.2 37.1  
 Female 49 58.2 44.5   46.7 34.9  
Age     0.096    0.382
 ≤ 60 104 64.5 53.6   53.5 40.6  
 > 60 80 54.3 43.8   42.3 31.3  
Location     0.228    0.500
 Upper 40 53.9 40.0   44.0 34.9  
 Middle 100 59.8 50.7   48.2 34.4  
 Lower 44 65.6 52.3   53.4 43.1  
Differentiation     0.217    0.048
 Grade 1 46 68.8 59.6   61.6 49.9  
 Grade 2 92 61.5 47.8   47.4 33.2  
 Grade 3 46 47.2 41.5   37.5 30.0  
pT category     0.064    0.098
 T1-2 44 67.8 61.4   57.0 48.3  
 T3-4 140 57.4 45.4   45.9 32.9  
pN category     0.000    0.000
 N0 100 76.9 65.7   69.2 53.6  
 N1-3 84 40.0 30.0   25.0 17.3  
Pathological staging     0.000    0.000
 I 13 92.3 80.8   92.3 71.2  
 II 92 72.3 61.8   62.8 50.1  
 III 79 40.2 29.6   25.4 15.8  
GSTM3 expression     0.132    0.016
 Low 91 56.2 46.0   39.2 26.8  
 High 93 64.6 52.8   57.4 45.1  
  1. #Kaplan-Meier method (log-rank test)
\